{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:47:20Z","timestamp":1790498840868,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["DFF-4092-00122"],"award-info":[{"award-number":["DFF-4092-00122"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005940","name":"Dansk Kr\u00e6ftforsknings Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jid.2018.03.1526","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T12:34:30Z","timestamp":1525782870000},"page":"1805-1815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["SATB1 in Malignant T Cells"],"prefix":"10.1016","volume":"138","author":[{"given":"Simon","family":"Fredholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Willerslev-Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zcan","family":"Met","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Kubat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Mathiasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Friese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edda","family":"Bl\u00fcmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengpeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Nastasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise M.","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terkild B.","family":"Buus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorbj\u00f8rn","family":"Krejsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz A.","family":"Wasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina L.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei B.","family":"Koralov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny L.","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"Bonefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Woetmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"\u00d8dum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2018.03.1526_bib1","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2018.03.1526_bib2","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2009-11-252205","article-title":"SATB1 dictates expression of multiple genes including IL-5 involved in human T helper cell differentiation","volume":"116","author":"Ahlfors","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.03.1526_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1101\/gad.14.5.521","article-title":"The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development","volume":"14","author":"Alvarez","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.jid.2018.03.1526_bib4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/1523-1747.ep12292129","article-title":"Enhanced expression of T-cell activation and natural killer cell antigens indicates systemic anti-tumor response in early primary cutaneous T-cell lymphoma","volume":"108","author":"Asadullah","year":"1997","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.03.1526_bib5","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood.V91.11.4331","article-title":"Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma","volume":"91","author":"Bagot","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.03.1526_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1749-6632.2001.tb03708.x","article-title":"Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas","volume":"941","author":"Bagot","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jid.2018.03.1526_bib7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK inhibitors in dermatology: the promise of a new drug class","volume":"76","author":"Damsky","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2018.03.1526_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11864-016-0410-8","article-title":"Genetics of cutaneous T cell lymphoma: from bench to bedside","volume":"17","author":"Damsky","year":"2016","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jid.2018.03.1526_bib9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1309\/YB79JG4TMJERQ7PV","article-title":"Primary Sezary syndrome commonly shows low-grade cytologic atypia and an absence of epidermotropism","volume":"123","author":"Diwan","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jid.2018.03.1526_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1523-1747.2000.00995.x","article-title":"Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis","volume":"115","author":"Echchakir","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.03.1526_bib11","first-page":"5277","article-title":"STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides","volume":"34","author":"Fredholm","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jid.2018.03.1526_bib12","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jid.2015.12.033","article-title":"The expression of IL-21 is promoted by MEKK4 in malignant T cells and associated with increased progression risk in cutaneous T-cell lymphoma","volume":"136","author":"Fredholm","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.03.1526_bib13","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood-2014-07-590398","article-title":"Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation","volume":"125","author":"Geskin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.03.1526_bib15","first-page":"101","article-title":"Correlation of SATB1 expression with clinical course of cutaneous T-cell lymphomas","volume":"63","author":"Grzanka","year":"2012","journal-title":"Pol J Pathol"},{"key":"10.1016\/j.jid.2018.03.1526_bib16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3892\/or.2014.3597","article-title":"Expression of special AT-rich sequence-binding protein 1 is an independent prognostic factor in cutaneous T-cell lymphoma","volume":"33","author":"Grzanka","year":"2015","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jid.2018.03.1526_bib17","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-12-3488","article-title":"TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma","volume":"19","author":"Guenova","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2018.03.1526_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.breast.2010.10.002","article-title":"SATB1 gene expression and breast cancer prognosis","volume":"20","author":"Hanker","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.jid.2018.03.1526_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaad.2014.09.022","article-title":"Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: diagnostic implications","volume":"72","author":"Hsi","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2018.03.1526_bib20","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/jnci\/djq243","article-title":"The role of SATB1 in breast cancer pathogenesis","volume":"102","author":"Iorns","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jid.2018.03.1526_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.21873\/anticanres.11006","article-title":"Expression of SATB1, MTI\/II and Ki-67 in mycosis fungoides","volume":"36","author":"Jankowska-Konsur","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jid.2018.03.1526_bib22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/asj\/sjw023","article-title":"Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma","volume":"36","author":"Kadin","year":"2016","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.jid.2018.03.1526_bib23","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.celrep.2017.04.038","article-title":"Essential roles of SATB1 in specifying T lymphocyte subsets","volume":"19","author":"Kakugawa","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2018.03.1526_bib24","doi-asserted-by":"crossref","first-page":"22769","DOI":"10.1074\/jbc.M116.735696","article-title":"SATB1 functions as an accessory factor in base excision repair","volume":"291","author":"Kaur","year":"2016","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2018.03.1526_bib25","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI24826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2018.03.1526_bib27","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4161\/cc.24987","article-title":"STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma","volume":"12","author":"Kopp","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jid.2018.03.1526_bib28","first-page":"209","article-title":"SATB1 is down-regulated in clear cell renal cell carcinoma and correlates with miR-21-5p overexpression and poor prognosis","volume":"13","author":"Kowalczyk","year":"2016","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.jid.2018.03.1526_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00281-016-0594-9","article-title":"Malignant inflammation in cutaneous T-cell lymphoma\u2014a hostile takeover","volume":"39","author":"Krejsgaard","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jid.2018.03.1526_bib30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood-2013-01-480889","article-title":"Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma","volume":"122","author":"Krejsgaard","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.03.1526_bib31","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/jid.2011.27","article-title":"Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3\/Stat3 signaling pathway","volume":"131","author":"Krejsgaard","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.03.1526_bib32","doi-asserted-by":"crossref","first-page":"15235","DOI":"10.18632\/oncotarget.3837","article-title":"Malignant T cells express lymphotoxin alpha and drive endothelial activation in cutaneous T cell lymphoma","volume":"6","author":"Lauenborg","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2018.03.1526_bib33","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.2000.00175.x","article-title":"Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanism for disease progression","volume":"115","author":"Levi","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.03.1526_bib34","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.4161\/15384101.2014.947759","article-title":"Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-dereved cell lines","volume":"13","author":"Litvinov","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jid.2018.03.1526_bib35","first-page":"981","article-title":"SATB1 is an independent prognostic marker for gastric cancer in a Chinese population","volume":"24","author":"Lu","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jid.2018.03.1526_bib36","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1007\/s13277-015-4638-x","article-title":"Downregulation of\u00a0SATB1 increases the invasiveness of Jurkat cell via activation of the WNT\/beta-catenin signaling pathway in\u00a0vitro","volume":"37","author":"Luo","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jid.2018.03.1526_bib37","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1158\/0008-5472.CAN-07-2403","article-title":"Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells","volume":"68","author":"Marzec","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2018.03.1526_bib38","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/labinvest.3700348","article-title":"Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3","volume":"85","author":"Marzec","year":"2005","journal-title":"Lab Invest"},{"key":"10.1016\/j.jid.2018.03.1526_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00384-011-1302-9","article-title":"Correlation of SATB1 overexpression with the progression of human rectal cancer","volume":"27","author":"Meng","year":"2012","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.jid.2018.03.1526_bib40","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1159\/000445558","article-title":"SATB1 is correlated with progression and metastasis of breast cancers: a meta-analysis","volume":"38","author":"Pan","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jid.2018.03.1526_bib41","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2133.2003.05224.x","article-title":"The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sezary syndrome","volume":"148","author":"Papadavid","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.03.1526_bib42","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/apm.12186","article-title":"miRNA in mycosis fungoides and skin inflammation","volume":"121","author":"Persson","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.jid.2018.03.1526_bib43","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1182\/blood.V128.22.1829.1829","article-title":"Preliminary results of a phase 1 trial evaluating MRG-106, a synthetic microRNA antagonist (LNA antimiR) of microRNA-155, in patients with CTCL","volume":"128","author":"Querfeld","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.03.1526_bib44","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1182\/blood-2011-06-358382","article-title":"Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)","volume":"118","author":"Ralfkiaer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.03.1526_bib45","first-page":"7207","article-title":"MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and adcanved cutaneous T cell lymphoma (CTCL)","volume":"34","author":"Ralfkiaer","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jid.2018.03.1526_bib46","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/jid.2014.487","article-title":"MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma","volume":"135","author":"Sandoval","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.03.1526_bib47","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/bjd.12909","article-title":"Prognostic factors, prognostic indices and staging in mycosis fungoides and Sezary syndrome: where are we now?","volume":"170","author":"Scarisbrick","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.03.1526_bib48","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","article-title":"Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and Sezary syndrome: effect of specific prognostic markers on survival and development of a prognostic model","volume":"33","author":"Scarisbrick","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2018.03.1526_bib49","doi-asserted-by":"crossref","first-page":"20555","DOI":"10.18632\/oncotarget.4111","article-title":"Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma","volume":"6","author":"Sibbesen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2018.03.1526_bib50","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.4049\/jimmunol.154.3.1167","article-title":"MHC class I signaling in T cells leads to tyrosine kinase activity and PLC-gamma 1 phosphorylation","volume":"154","author":"Skov","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2018.03.1526_bib51","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00262-007-0285-4","article-title":"Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors","volume":"56","author":"Sondergaard","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jid.2018.03.1526_bib52","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ijc.2910490218","article-title":"Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor","volume":"49","author":"Starkebaum","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2018.03.1526_bib53","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin\u2019s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.03.1526_bib54","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/jid.2010.349","article-title":"MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sezary syndrome","volume":"131","author":"van der Fits","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.03.1526_bib55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molonc.2011.02.003","article-title":"miRNA expression profiling of mycosis fungoides","volume":"5","author":"van Kester","year":"2011","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jid.2018.03.1526_bib56","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1200\/JCO.2001.19.23.4322","article-title":"CD8+ T cells in cutaneous T-cell lymphoma: expression of\u00a0cytotoxic proteins, Fas ligand, and killing inhibitory receptors and\u00a0their relationship with clinical behavior","volume":"19","author":"Vermeer","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2018.03.1526_bib57","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1158\/1078-0432.CCR-15-1784","article-title":"STAT3\/5-dependent IL9 overexpression contributes to neoplastic cell survival in mycosis fungoides","volume":"22","author":"Vieyra-Garcia","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2018.03.1526_bib58","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.03.1526_bib59","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood-2013-10-534693","article-title":"SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.03.1526_bib60","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1182\/blood-2010-07-294819","article-title":"Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL\/CD95L transcription","volume":"117","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.03.1526_bib61","doi-asserted-by":"crossref","first-page":"28961","DOI":"10.18632\/oncotarget.5009","article-title":"Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2018.03.1526_bib62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.24233","article-title":"Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management","volume":"91","author":"Wilcox","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jid.2018.03.1526_bib63","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.03.1526_bib65","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4161\/cc.28256","article-title":"IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF)","volume":"13","author":"Willerslev-Olsen","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jid.2018.03.1526_bib66","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood-2006-04-017863","article-title":"Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins","volume":"109","author":"Woetmann","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.03.1526_bib67","first-page":"2256","article-title":"Expression of SATB1 and HER2 in gastric cancer and its clinical significance","volume":"20","author":"Yuan","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jid.2018.03.1526_bib69","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1073\/pnas.0501959102","article-title":"STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2018.03.1526_bib70","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.4238\/2015.April.13.10","article-title":"Expression and significance of SATB1 in the development of breast cancer","volume":"14","author":"Zhang","year":"2015","journal-title":"Genet Mol Res"},{"issue":"6","key":"10.1016\/j.jid.2018.03.1526_bib71","doi-asserted-by":"crossref","first-page":"e100413","DOI":"10.1371\/journal.pone.0100413","article-title":"Expression of SATB1 promotes the growth and metastasis of colorectal cancer","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18319560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18319560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:11:03Z","timestamp":1758301863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X18319560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0022202X18319560"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2018.03.1526","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SATB1 in Malignant T Cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.03.1526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.02.028","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.04.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}